CN EN

About us

Who We Are

A stellar compliance record following global standards

BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research, development, and manufacturing organization (CRDMO) with over 28 years of expertise. Global headquarter in Irvine, California, our global presence spans 7 sites across 6 cities, totaling nearly 3,000 employees. Specializing in small and large molecule discovery, development, scale-up and manufacturing, we offer fully integrated services from target identification to commercial drug product manufacturing. 

At BioDuro-Sundia, we leverage our unique technology platforms to support biotech and pharmaceutical partners worldwide. Our comprehensive approach accelerates discovery, de-risks development, and creates higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, diversified and people-focused culture. 

Dedicated to CRDMO Service business, BioDuro-Sundia operates under one global standard, providing top-tier, integrated, fast, and flexible tailored services to meet the unique needs of our clients and accelerate development timelines.

28
Years
Founded in US in 1996
~2,300
Active Projects
~3,000
Staff Worldwide
1,500
+
Active Customers
7
Facilities Across 6
Cities Globally

Our Investors

A portfolio company of Advent International & Bridgewest Group
Advent: leading global private equity, headquartered in Boston
Bridgewest: California-based pharma and life sciences investor

Learn more

Our Mission

To be the TRUSTED partner delivering world-class drug discovery,
development and manufacturing services
CORPORATE VALUES: ARTRI
ACCOUNTABILITY
We always take responsibility for our actions and behavior and conduct ourselves to established metrics of high performance.
RESPECT
We deeply respect our employees and clients, within a family structure, based on equality and understanding.
TENACITY
We know we may face adversity, but will never give up, but persevere to succeed.
RESULTS
We establish clear measures of success and deliver results to our internal and external stakeholders.
INTEGRITY
We are honest with ourselves and transparent in our actions and hold Intellectual Property (IP) standards at the highest level.

Global Presence

Global headquarter in Irvine, CA, with centers of operational excellence in both US and China

Learn more

Our History

We went through multiple successful integrations and have embarked on the next phase of growth to deliver more value to customers

2023

San Diego and Irvine facilities consolidated operations and quality systems; Irvine site continues to perform pre-clinical, clinical, commercial programs; Registration batches manufactured on 27 mm extruder

2022

Irvine facilities continued commercial manufacturing for Endo products as a CDMO

2021

BioDuro-Sundia acquired two US-based drug product manufacturing facilities (100,000 sq. ft. clinical and commercial capacity) from Endo (previously Par/Anchen)

Completed 1st GMP drug product manufacturing at new R&D center in Jiangshu, China

2020

BioDuro acquired Sundia to become BioDuro-Sundia, one of the largest CRDMOs worldwide

300,000 sq. ft. Jiangsu facility opened with integrated capabilities across discovery and GMP manufacturing

2019

Advent buys majority stake in BioDuro and becomes majority investor of BioDuro

2018

BioDuro acquired Molecular Response ("Tumor Bank")

2015

BioDuro reacquired from PPD; BioDuro and Formex merged to enable broad range of service offerings

2013

Formex (previously Pharmaform) joined Bridgewest Group (44,000 sq. ft. GMP facilities)

2012

93,000 sq. ft. Shanghai facilities (72,000 sq. ft. lab) opened to meet growing client demand

2009

BioDuro acquired by PPD

2007

Sundia merged with United Pharma

2006

100,000 sq. ft. facility in Beijing for drug discovery services fully operational

2005

BioDuro founded in San Diego by Biotech Investment Group (formed by Bridgewest Group) with first drug discovery operations in Beijing facilities

2004

Sundia founded (later acquired by BioDuro)

2002

Anchen founded (legacy company for BioDuro Irvine)

1996

Pharmaform founded (legacy company for BioDuro San Diego) as pioneer of HME services in oral product development

Business Ethics

Business Conduct and Ethics

At BioDuro-Sundia, we operate with integrity and strict standards of law and business ethics, which are our fundamental guidelines in all locations. We adhere to the business ethics of legal compliance, integrity, and self-discipline, and always strictly comply with laws and regulations related to corporate governance and the Corporate Governance Code with zero tolerance for any form of corruption. We have built a strong security infrastructure that protects and preserves the intellectual property and data of our customers; We are implementing green manufacturing and sustainable operations across our business units, helping to improve the environment and our communities.

Learn more
0.166217s
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all